BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 231 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,491,000 | +7.7% | 10,230 | -12.4% | 0.01% | +33.3% |
| Q1 2022 | $1,384,000 | -22.9% | 11,673 | -9.7% | 0.01% | +20.0% |
| Q3 2021 | $1,796,000 | +240.2% | 12,927 | +137.6% | 0.01% | +150.0% |
| Q2 2021 | $528,000 | -41.0% | 5,441 | -60.5% | 0.00% | -83.3% |
| Q3 2020 | $895,000 | +30.1% | 13,774 | -31.9% | 0.01% | -33.3% |
| Q1 2020 | $688,000 | -66.9% | 20,213 | -47.1% | 0.02% | +50.0% |
| Q4 2019 | $2,081,000 | +70.2% | 38,229 | +30.4% | 0.01% | +9.1% |
| Q3 2019 | $1,223,000 | -54.1% | 29,312 | -51.8% | 0.01% | -57.7% |
| Q2 2019 | $2,663,000 | -36.4% | 60,824 | -25.3% | 0.03% | -40.9% |
| Q1 2019 | $4,190,000 | +103.8% | 81,401 | +46.4% | 0.04% | +83.3% |
| Q4 2018 | $2,056,000 | -0.2% | 55,601 | +1.4% | 0.02% | -4.0% |
| Q3 2018 | $2,060,000 | +257.0% | 54,856 | +275.7% | 0.02% | +212.5% |
| Q2 2018 | $577,000 | +121.9% | 14,600 | +44.6% | 0.01% | +100.0% |
| Q1 2018 | $260,000 | -55.3% | 10,100 | -53.2% | 0.00% | -60.0% |
| Q4 2017 | $582,000 | – | 21,565 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 896,844 | $123,594,000 | 67.92% |
| RP Management, LLC | 1,111,111 | $153,122,000 | 64.09% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,075,402 | $286,011,000 | 40.64% |
| ARS Investment Partners, LLC | 463,392 | $63,860,000 | 5.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 300,373 | $41,394,000 | 4.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 80,348 | $11,073,000 | 4.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,900 | $19,282,000 | 4.30% |
| Avidity Partners Management LP | 1,140,000 | $157,103,000 | 3.33% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $27,562,000 | 3.17% |
| Eventide Asset Management | 1,635,000 | $225,319,000 | 2.88% |